Name Gregory E. Kaebnick David Christopher Magnus Audiey Kao Mohammad Hosseini David Resnik Veljko Dubljević Christy Rentmeester Bert Gordijn | Source meta
Gregory E. Kaebnick David Christopher Magnus Audiey Kao Mohammad Hosseini David Resnik Veljko Dubljević Christy Rentmeester Bert Gordijn
Related posts
Pursuing Fair and Just Compensation for Research Participants: An Open Letter to the Research Ethics Community
This editorial appears in the July 2025 issue of the American Journal of Bioethics. A cornerstone of modern research ethics oversight is the avoidance of undue influence on potential research participants to enroll in studies. Yet little guidance is given as to what influence is “undue”. Concerns over undue influence often arise in discussions of payment […]
The Climate is Changing. Should Clinical Ethics Change, Too?
This editorial appears in the July 2025 issue of the American Journal of Bioethics In June 2021, Dr. Kyle Merritt made international news when he admitted a female septuagenarian to a hospital in British Columbia, charting her chief complaint as dehydration and exacerbated asthma due to climate change. A diagnosis of “climate change” is unconventional, but […]
Do Not Pervert Justice
Do Not Pervert Justice. (Leviticus 19:15) “Woe to those who make unjust laws, to those who issue oppressive decrees, to deprive the poor of their rights and withhold justice from the oppressed of my people, making widows their prey and robbing homeless children.” (Isaiah 10:1-2)” In September of 2016, then Republican presidential candidate Donald […]
Prescribing Ozempic and an Obligation to Lose Weight
Prescriptions of GLP-1 drugs to patients without diabetes have seen an increase of 700% since 2019. GLP-1 drugs like Ozempic and Mounjaro were originally used to treat Type 2 diabetes and to reduce the risks of heart attack and stroke. Now they are also prescribed off-label for the purpose of weight loss, especially for […]